The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: November 2023

October 17, 2025
Highlights in Cancer Research: November 2022

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.

11. MYC determines lineage commitment in KRAS-driven primary liver cancer development

  • 1. Mitotic clustering of pulverized chromosomes from micronuclei
  • 2. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
  • 3.
  • 4. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
  • 5. Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation
  • 6. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits
  • 7. Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis
  • 8. Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
  • 9. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
  • 10. VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry
  • 11. MYC determines lineage commitment in KRAS-driven primary liver cancer development
Previous
Next

D’Artista, L. et al. Journal of Hepatology. 79(1):141-149 (2023).
doi: 10.1016/j.jhep.2023.02.039.

Summary, future impact and graphical abstract by Alexandra Boitor, EACR Scientific Officer

Summary of the findings

In this paper, D’Artista et al are investigating both the “cell of origin” and the molecular mechanisms that govern the development of primary tumours in the liver. Building upon previous work demonstrating that hepatocytes pose increased plasticity, the authors implicate MYC as a master regulator in lineage commitment in primary liver cancer. More exactly, the authors of this paper suggest that high MYC levels and MYC controlled transcriptional activity of FOXA1, FOXA2 and ETS1 can determine the commitment of malignant hepatocytes towards hepatocellular carcinoma. The overexpression of Ets1 together with shRNA targeting Foxa1 and Foxa2 in MYC transformed hepatocytes caused a switch from hepatocellular carcinoma to intrahepatic cholangiocarcinoma development (as shown in the Figure).

Future impact

The authors highlight the relevance of their findings for regenerative medicine and modulation of cancer response to treatment.

Read more in Journal of Hepatology

 

11. MYC determines lineage commitment in KRAS-driven primary liver cancer development

  • 1. Mitotic clustering of pulverized chromosomes from micronuclei
  • 2. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding
  • 3.
  • 4. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or Ovarian Cancer
  • 5. Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation
  • 6. Machine learning identifies experimental brain metastasis subtypes based on their influence on neural circuits
  • 7. Early Infiltration of Innate Immune Cells to the Liver Depletes HNF4α and Promotes Extrahepatic Carcinogenesis
  • 8. Combinatorial BCL2 Family Expression in Acute Myeloid Leukemia Stem Cells Predicts Clinical Response to Azacitidine/Venetoclax.
  • 9. Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation
  • 10. VE-Cadherin modulates β-catenin/TCF-4 to enhance Vasculogenic Mimicry
  • 11. MYC determines lineage commitment in KRAS-driven primary liver cancer development
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

Magdalena Sznurkowska’s EACR-AstraZeneca Postdoctoral Fellowship – Final Report

Magdalena Sznurkowska’s EACR-AstraZeneca Postdoctoral Fellowship – Final Report

October 12, 2026

Magdalena Sznurkowska was the 2024 recipient of an EACR-AstraZeneca Postdoctoral Fellowship, funding that is awarded for a period of up to three years to support excellent...

“An exchange that has had a lasting impact on my research, my laboratory and my development as a cancer researcher”:  Peijin Jiang’s Travel Fellowship

“An exchange that has had a lasting impact on my research, my laboratory and my development as a cancer researcher”: Peijin Jiang’s Travel Fellowship

September 23, 2026

Peijin Jiang is a PhD student at the Vall d’Hebrón Institute of Oncology (VHIO), Spain, who received an EACR Travel Fellowship to visit and work at...

“Practical insights into leadership, communication, negotiation, and career development”: Inside the 2026 Women in Leadership Workshop

“Practical insights into leadership, communication, negotiation, and career development”: Inside the 2026 Women in Leadership Workshop

September 11, 2026

" provided practical insights into leadership, communication, negotiation, and career development that directly align with the challenges of establishing and leading an independent multidisciplinary research program....

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

Advertisement Advertisement Advertisement
ADVERTISEMENT

RECENT POSTS

Magdalena Sznurkowska’s EACR-AstraZeneca Postdoctoral Fellowship – Final Report
Career

Magdalena Sznurkowska’s EACR-AstraZeneca Postdoctoral Fellowship – Final Report

October 12, 2026
VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution
News

VIDEO | Transcriptome and repertoire profiling of infiltrating γδ T cells to decode tumor escape at single cell resolution

October 8, 2026
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR